4.7 Article

Carfentanil is a β-arrestin-biased agonist at the μ opioid receptor

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

A novel G protein-biased agonist at the μ opioid receptor induces substantial receptor desensitisation through G protein-coupled receptor kinase

Sam Groom et al.

Summary: This study confirmed that Compound 1 is a G protein-biased mu agonist that can induce substantial rapid receptor desensitisation in mammalian neurons. However, contrary to previous assumptions, the desensitisation effect of Compound 1 is dependent on G protein-coupled receptor kinase (GRK).

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Review Pharmacology & Pharmacy

The anomalous pharmacology of fentanyl

Eamonn Kelly et al.

Summary: Fentanyl is a key therapeutic drug used in anaesthesia and pain management, but its illicit use has led to a significant increase in opioid overdose deaths. This review examines the unique pharmacological properties of fentanyl and explores whether these properties contribute to overdose deaths involving fentanyl.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Article Pharmacology & Pharmacy

Attenuation of the Positive-Reinforcing Effects of Ultra-Potent Fentanyl Analogs, Along with Those of Fentanyl and Heroin, During Daily Treatment with Methocinnamox in Rhesus Monkeys

Lisa R. Gerak et al.

Summary: The opioid crisis will continue without intervention, emphasizing the need for new treatments for opioid use disorder (OUD). Methocinnamox (MCAM), a new m opioid receptor antagonist, shows promise in blocking the effects of fentanyl analogs, but questions remain about its utility. This study investigates MCAM's effectiveness in attenuating the abuse-related effects of carfentanil and 3-methylfentanyl compared to other drugs.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2023)

Article Multidisciplinary Sciences

Structure-based design of bitopic ligands for the mu-opioid receptor

Abdelfattah Faouzi et al.

Summary: Researchers have developed a new approach to design safer therapeutic agents by targeting a conserved sodium ion-binding site in mu-opioid receptors. Cryo-electron microscopy structures revealed the key interactions between the ligands and the binding site, leading to the development of potent ligands with reduced adverse effects. This study highlights the potential of targeting the sodium ion-binding site for the design of safer analgesics and suggests that engagement of this site can control the efficacy and selectivity profiles of G-protein-coupled receptors.

NATURE (2023)

Article Biochemistry & Molecular Biology

Insights into distinct signaling profiles of the μOR activated by diverse agonists

Qianhui Qu et al.

Summary: This study investigated the mechanistic basis of action of two mu-opioid receptor (mu OR) agonists, LFT and MP, with different safety profiles, and found that they exhibited markedly different efficacy profiles for G protein subtype activation and beta-arrestin recruitment.

NATURE CHEMICAL BIOLOGY (2023)

Review Pharmacology & Pharmacy

Biased Agonism: Lessons from Studies of Opioid Receptor Agonists

Eamonn Kelly et al.

Summary: In ligand bias, different agonist drugs activate distinct signaling pathways, leading to different therapeutic and adverse effects. While it was believed that selectively activating the G protein-dependent pathway of the mu-opioid receptor would result in effective analgesia without adverse effects, recent data suggest that most effects are mediated by this pathway and some drugs described as biased may actually be low-intrinsic-efficacy agonists. This review discusses the current understanding of bias at the mu-opioid receptor and other opioid receptor subtypes.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2023)

Article Biochemistry & Molecular Biology

Assessment of abuse potential of carfentanil

Jiayun Wei et al.

Summary: In this study, the abuse potential of Carfentanil was evaluated. The results showed that Carfentanil had a higher ability to induce conditioned place preference and self-administration compared to Fentanyl and heroin. Additionally, Carfentanil can also cause physical dependence, similar to Fentanyl and heroin.

ADDICTION BIOLOGY (2023)

Article Multidisciplinary Sciences

Structure-based design of bitopic ligands for the μ-opioid receptor

Abdelfattah Faouzi et al.

Summary: This study presents an approach to design safer analgesics by targeting a conserved sodium ion-binding site in mu-opioid receptor (mu OR) using bitopic fentanyl derivatives. Cryo-electron microscopy structures reveal key interactions between the ligands and mu OR, demonstrating nanomolar potency, high efficacy, and reduced adverse effects. This study suggests the potential of the mu OR sodium ion-binding site as a target for the design of safer analgesics.

NATURE (2023)

Review Pharmacology & Pharmacy

Community guidelines for GPCR ligand bias: IUPHAR review 32

Peter Kolb et al.

Summary: GPCRs regulate various physiological processes and their effects depend on the pairing of a receptor and a ligand. Ligands that induce biased signalling can lead to better drug effects and fewer side effects. However, ligand bias is complex, making it necessary to develop guidelines for designing and reporting biased signalling experiments.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Editorial Material Pharmacology & Pharmacy

Planning experiments: Updated guidance on experimental design and analysis and their reporting III

Michael J. Curtis et al.

Summary: This editorial provides guidance for scientists planning to publish in the British Journal of Pharmacology (BJP) and updates the requirements on experimental design and analysis for BJP manuscripts. It addresses new issues that have arisen in the course of handling manuscripts and emphasizes three challenging aspects of design: randomization, blinded analysis, and balance of group sizes.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Biology

Endocytic trafficking determines cellular tolerance of presynaptic opioid signaling

Damien Jullie et al.

Summary: This study reveals the cellular mechanism underlying opioid tolerance, mainly through presynaptic tolerance and the endocytosis and recycling process of opioid receptors. The endocytic process of the μ-opioid receptor (MOR) requires phosphorylation mediated by GRK2/3, while the endocytosis of the δ-opioid receptor (DOR) does not require this process. In addition, DOR has a lower efficiency of recycling, resulting in stronger tolerance.
Article Pharmacology & Pharmacy

Tyrosine 7.43 is important for mu-opioid receptor downstream signaling pathways activated by fentanyl

Xiangyun Tian et al.

Summary: This study investigated the effects of Y7.43 mutation on the signaling pathways of MOR using molecular docking and molecular dynamics simulations. The results showed that Y7.43 mutation reduced the activation of the G(i/o) protein pathway, blocked the recruitment of ss-arrestin2, increased the outward movement of H6 in MOR, and disrupted hydrophobic interactions. These findings are important for the design of new drugs and the optimization of synthesized compound structures.

FRONTIERS IN PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Molecular recognition of morphine and fentanyl by the human μ-opioid receptor

Youwen Zhuang et al.

Summary: This study reports the structural differences in the binding of morphine and fentanyl to the human mu-opioid receptor (mu OR), as well as the preferential interactions of other agonists with specific regions of the receptor. Mutations at certain regions abolish the recruitment of arrestin by morphine and fentanyl. Ligands designed to reduce interactions with specific regions display preferential G protein signaling. These findings provide crucial insights into the recognition and signaling of fentanyl, which could aid in the rational design of next-generation analgesics.
Article Biochemistry & Molecular Biology

A comprehensive evaluation of the potential binding poses of fentanyl and its analogs at the l-opioid receptor

Bing Xie et al.

Summary: Fentanyl and its analogs are selective agonists of the l-opioid receptor, but the binding mechanism of fentanyl at the receptor is still not fully understood. This study used computational methods to investigate the preferred conformations of fentanyl and how they bind to the receptor. The results showed that the most preferred binding pose in the receptor corresponds to the global minimum on the energy landscape of fentanyl, and the interactions with the receptor can stabilize unfavorable fentanyl conformations. These findings provide insights into the potential toxicity of new synthetic opioids and contribute to the development of safer analgesics.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)

Article Chemistry, Medicinal

Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns

Adrian Ricarte et al.

Summary: This study used molecular dynamics simulations to reveal differences in the interactions of fentanyl and morphine with the MOR, highlighting distinct ligand-receptor binding modes and intracellular receptor conformational changes. The observations may provide insights for designing safer but equally effective opioid drugs by understanding the functional variances between fentanyl and morphine.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)

Article Pharmacology & Pharmacy

TRV130 partial agonism and capacity to induce anti-nociceptive tolerance revealed through reducing available μ-opioid receptor number

Samuel Singleton et al.

Summary: The study revealed that TRV130 and PZM21 exhibit partial agonism in beta-arrestin2 recruitment assay, and reduced mu-receptor availability limits the efficacy of TRV130, also revealing morphine and PZM21 to be partial agonists. Despite limited efficacy in vitro, TRV130 demonstrated potent anti-nociception in wild-type mice without tolerance after daily administration.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Review Medicine, Legal

Carfentanil-from an animal anesthetic to a deadly illicit drug

Jolanta B. Zawilska et al.

Summary: The use of novel synthetic opioids as recreational drugs has raised public health concern, with carfentanil being one of the most dangerous derivatives. Toxic exposure to carfentanil typically occurs through injection, insufflation or inhalation, necessitating the development of rapid detection and treatment regimens for its intoxication.

FORENSIC SCIENCE INTERNATIONAL (2021)

Article Multidisciplinary Sciences

How μ-opioid receptor recognizes fentanyl

Quynh N. Vo et al.

Summary: This research elucidates the detailed binding mechanism of fentanyl in mOR, identifying a secondary binding mode that is only accessible when His297 is in a neutral HID tautomer state.

NATURE COMMUNICATIONS (2021)

Article Pharmacology & Pharmacy

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors

Stephen P. H. Alexander et al.

Summary: The Concise Guide to PHARMACOLOGY 2021/22 presents concise overviews of nearly 1900 human drug targets with an emphasis on selective pharmacology, along with links to a more detailed knowledgebase. It serves as a permanent, citable record for researchers, providing useful information in the field of pharmacology.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Article Pharmacology & Pharmacy

Fentanyl depression of respiration: Comparison with heroin and morphine

Rob Hill et al.

BRITISH JOURNAL OF PHARMACOLOGY (2020)

Article Pharmacology & Pharmacy

Morphine-induced respiratory depression is independent of β-arrestin2 signalling

Andrea Kliewer et al.

BRITISH JOURNAL OF PHARMACOLOGY (2020)

Article Biochemical Research Methods

Molecular mechanisms of fentanyl mediated β-arrestin biased signaling

Parker W. de Waal et al.

PLoS Computational Biology (2020)

Editorial Material Pharmacology & Pharmacy

ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020

Elliott Lilley et al.

BRITISH JOURNAL OF PHARMACOLOGY (2020)

Article Pharmacology & Pharmacy

Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors

Amy J. Eshleman et al.

BIOCHEMICAL PHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research

Nathalie Percie du Sert et al.

PLOS BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational Analysis

Piotr F. J. Lipinski et al.

MOLECULES (2019)

Article Biochemistry & Molecular Biology

Molecular dynamics of fentanyl bound to -opioid receptor

Piotr F. J. Lipinski et al.

JOURNAL OF MOLECULAR MODELING (2019)

Review Anesthesiology

Carfentanil: a narrative review of its pharmacology and public health concerns

Jessica L. S. Leen et al.

CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2019)

Review Medical Laboratory Technology

The Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union

Paul J. Jannetto et al.

CLINICAL CHEMISTRY (2019)

Review Behavioral Sciences

Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment

Sandra D. Comer et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)

Review Biochemistry & Molecular Biology

DARK Classics in Chemical Neuroscience: Fentanyl

S. Mallory Burns et al.

ACS CHEMICAL NEUROSCIENCE (2018)

Review Medicine, Legal

Abuse of fentanyl: An emerging problem to face

Katarzyna Kuczynska et al.

FORENSIC SCIENCE INTERNATIONAL (2018)

Article Biochemistry & Molecular Biology

Drug Binding Poses Relate Structure with Efficacy in the μ Opioid Receptor

Katy J. Sutcliffe et al.

JOURNAL OF MOLECULAR BIOLOGY (2017)

Article Biochemistry & Molecular Biology

Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics

Cullen L. Schmid et al.

Article Chemistry, Multidisciplinary

The FMO analysis of the molecular interaction of fentanyl derivatives with the μ-opioid receptor

Malgorzata Jaronczyk et al.

CHEMICAL PAPERS (2017)

Review Substance Abuse

A review: Fentanyl and non-pharmaceutical fentanyls

Joji Suzuki et al.

DRUG AND ALCOHOL DEPENDENCE (2017)

Article Biochemistry & Molecular Biology

Crystal Structure of an LSD-Bound Human Serotonin Receptor

Daniel Wacker et al.

Review Pharmacology & Pharmacy

Superagonism at G protein-coupled receptors and beyond

R. Schrage et al.

BRITISH JOURNAL OF PHARMACOLOGY (2016)

Article Multidisciplinary Sciences

The role of kinetic context in apparent biased agonism at GPCRs

Carmen Klein Herenbrink et al.

NATURE COMMUNICATIONS (2016)

Article Chemistry, Physical

ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB

James A. Maier et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)

Article Multidisciplinary Sciences

Structural insights into μ-opioid receptor activation

Weijiao Huang et al.

NATURE (2015)

Article Computer Science, Hardware & Architecture

High performance in silico virtual drug screening on many-core processors

Simon McIntosh-Smith et al.

INTERNATIONAL JOURNAL OF HIGH PERFORMANCE COMPUTING APPLICATIONS (2015)

Article Chemistry, Physical

Lipid14: The Amber Lipid Force Field

Callum J. Dickson et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2014)

Article Clinical Neurology

The Fentanyl Story

Theodore H. Stanley

JOURNAL OF PAIN (2014)

Article Pharmacology & Pharmacy

Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor

R. Schrage et al.

BRITISH JOURNAL OF PHARMACOLOGY (2013)

Review Pharmacology & Pharmacy

Efficacy and ligand bias at the μ-opioid receptor

E. Kelly

BRITISH JOURNAL OF PHARMACOLOGY (2013)

Article Chemistry, Physical

PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data

Daniel R. Roe et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2013)

Review Pharmacology & Pharmacy

Regulation of mu-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and Tolerance

John T. Williams et al.

PHARMACOLOGICAL REVIEWS (2013)

Article Biochemistry & Molecular Biology

A Simple Method for Quantifying Functional Selectivity and Agonist Bias

Terry Kenakin et al.

ACS CHEMICAL NEUROSCIENCE (2012)

Review Pharmacology & Pharmacy

Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons

Vu C. Dang et al.

BRITISH JOURNAL OF PHARMACOLOGY (2012)

Review Pharmacology & Pharmacy

Probing Heterotrimeric G Protein Activation: Applications to Biased Ligands

Colette Denis et al.

CURRENT PHARMACEUTICAL DESIGN (2012)

Article Multidisciplinary Sciences

Crystal structure of the μ-opioid receptor bound to a morphinan antagonist

Aashish Manglik et al.

NATURE (2012)

Article Pharmacology & Pharmacy

Endomorphin-2: A Biased Agonist at the μ-Opioid Receptor

Guadalupe Rivero et al.

MOLECULAR PHARMACOLOGY (2012)

Article Clinical Neurology

Basic opioid pharmacology: an update

Hasan Pathan et al.

BRITISH JOURNAL OF PAIN (2012)

Review Anesthesiology

Molecular Mechanisms of Opioid Receptor-dependent Signaling and Behavior

Ream Al-Hasani et al.

ANESTHESIOLOGY (2011)

Article Emergency Medicine

HUMAN HEALTH HAZARDS OF VETERINARY MEDICATIONS: INFORMATION FOR EMERGENCY DEPARTMENTS

Elaine Blythe Lust et al.

JOURNAL OF EMERGENCY MEDICINE (2011)

Review Pharmacology & Pharmacy

β-arrestin-mediated receptor trafficking and signal transduction

Sudha K. Shenoy et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2011)

Letter Emergency Medicine

Carfentanil-an ultra potent opioid

Antony V. George et al.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2010)

Article Pharmacology & Pharmacy

mu-Opioid Receptors: Correlation of Agonist Efficacy for Signalling with Ability to Activate Internalization

Jamie McPherson et al.

MOLECULAR PHARMACOLOGY (2010)

Article Pharmacology & Pharmacy

Agonist-selective mechanisms of GPCR desensitization

E. Kelly et al.

BRITISH JOURNAL OF PHARMACOLOGY (2008)

Article Chemistry, Multidisciplinary

Software news and updates - CHARNIM-GUI: A web-based grraphical user interface for CHARMM

Sunhwan Jo et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2008)

Article Pharmacology & Pharmacy

Agonist-selective mechanisms of μ-opioid receptor desensitization in human embryonic kidney 293 cells

Elizabeth A. Johnson et al.

MOLECULAR PHARMACOLOGY (2006)

Article Biochemistry & Molecular Biology

Steric interactions and the activity of fentanyl analogs at the μ-opioid receptor

L Dosen-Micovic et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2006)

Article Chemistry, Multidisciplinary

Development and testing of a general amber force field

JM Wang et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)

Article Chemistry, Multidisciplinary

UCSF chimera - A visualization system for exploratory research and analysis

EF Pettersen et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)

Review Chemistry, Medicinal

Molecular docking reveals a novel binding site model for fentanyl at the μ-opioid receptor

G Subramanian et al.

JOURNAL OF MEDICINAL CHEMISTRY (2000)